RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On August 5, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2026 and updating financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on August 5, 2026 at 4:30pm Eastern…

Entry into a Material Definitive Agreement On June 24, 2026, KORU Medical Systems, Inc. (the “Company”) entered into that certain Amendment No. 1 to Amended and Restated Manufacturing and Supply Agreement (the “Amendment”) with Command Medical Products, LLC (“Command”), which amends that certain Amended and Restated Manufacturing and Supply Agreement dated January 1, 2024 between the Company and Command (the “Agreement”). Under the Agreement, Command manufactures and supplies the Company’s su…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On May 6, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2026 and reiterating financial guidance for the fiscal year ended December 31, 2026. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on May 6, 2026 at 4:30pm Eastern Tim…

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. Reference is made to the disclosure under

CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT. On March 30, 2026, KORU Medical Systems, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its loan and security agreement, by and between the Company and HSBC Ventures USA Inc., as lender, dated March 8, 2024, as amended (the “Loan and Security Agreement”), relating to a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the “R…

CEO — Linda Tharby: Linda Tharby is retiring as CEO with a planned succession by Mr. Kalbermatten.

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On March 12, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the fourth fiscal quarter and full year ended December 31, 2025 and financial guidance for the fiscal year ended December 31, 2026. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on March 12, 2026 at 4:30pm…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On January 12, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary financial results for the fiscal quarter and year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The preliminary financial results included in the press release are based on the Company’s current estimate of its results for…

Entry into a Material Definitive Agreement On November 19, 2025, the Company entered into an Amended and Restated Manufacturing and Supply Agreement (the “Agreement”) with Command Medical Products, Inc. (“Command”), pursuant to which Command has agreed to manufacture and supply the Company’s subassemblies, needle sets and tubing products pursuant to the Company’s specifications and purchase orders. The Agreement, which is effective as of January 1, 2024, amends and restates in its entirety th…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On November 12, 2025, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2025 and updated financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on November 12, 2025 at 4:30pm…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On August 6, 2025, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2025 and updated financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on August 6, 2025 at 4:30pm Eastern Time. KO…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On May 7, 2025, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2025 and updated financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on May 7, 2025 at 4:30pm Eastern Time. KORU Med…

Chief Commercial Officer — Kenneth Miller: Kenneth Miller resigned to pursue a CEO role at another organization.

is being furnished and shall not be deemed to be “filed” with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such a filing. Forw…

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On March 31, 2025, KORU Medical Systems, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its loan and security agreement, by and between the Company and HSBC Ventures USA Inc., as lender, dated March 8, 2024 (the “Loan and Security Agreement”). The Company has not drawn on the credit facility under the Loan and Security Agreement, and there is no obligation for the Company to do so at any time. The Amendment extends the maturity…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On March 12, 2025, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2024 and financial guidance for the fiscal year ended December 31, 2025. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on March 12, 2025 at 4:30pm Eastern Tim…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On January 13, 2025, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary financial results for the fiscal quarter and year ended December 31, 2024. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The preliminary financial results included in the press release are based on the Company’s current estimate of its results for…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On November 13, 2024, KORU Medical Systems, Inc. (“KORU Medical” or “we”) issued a press release announcing its financial results for the fiscal quarter ended September 30, 2024. A related conference call will be held on November 13, 2024 at 4:30 pm Eastern Time. KORU Medical is making reference to non-GAAP financial measures in both the press release and the conference call. Our management believes that investors’ understanding of KORU Medical’s…

The filing describes the approval and details of a Long-Term Incentive Program (LTIP) for executives and other employees.

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On August 7, 2024, KORU Medical Systems, Inc. (“KORU Medical” or “we”) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2024. A related conference call will be held on August 7, 2024 at 4:30 pm Eastern Time. KORU Medical is making reference to non-GAAP financial measures in both the press release and the conference call. Our management believes that investors’ understanding of KORU Medical’s performanc…

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On July 24, 2024, the Company announced that Christopher Pazdan, the Senior Vice President, Operations of KORU Medical Systems, Inc. (the “Company”), was appointed to the newly-created position of Chief Operating Officer of the Company, effective July 18, 2024. In connection with his appointment, Mr. Pazdan entered into an Amended and Restated Employment Agreement with the Company dated as of July 18, 2024 (the “A&R Employment Agreement”). The follo…

Chief Technology Officer — Brian Case: The position of Chief Technology Officer was eliminated, leading to Mr. Case's departure.

Changes in Registrant’s Certifying Accountant. (a) On June 3, 2024, the Audit Committee (the “Audit Committee”) of the board of directors of the Company approved the dismissal of McGrail Merkel Quinn & Associates, P.C. (“MMQ”) as the Company’s independent registered public accounting firm, effective immediately. The reports of MMQ on the Company’s financial statements for each of the two fiscal years ended December 31, 2023 and December 31, 2022 did not contain an adverse opinion or a disclai…

RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On May 1, 2024, KORU Medical Systems, Inc. (“KORU Medical” or “we”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2024. A related conference call will be held on May 1, 2024 at 4:30 pm Eastern Time. KORU Medical is making reference to non-GAAP financial measures in both the press release and the conference call. Our management believes that investors’ understanding of KORU Medical’s performance is…

UNREGISTERED SALES OF EQUITY SECURITIES. The disclosure set forth in